cromakalim has been researched along with diphenyleneiodonium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, KW; Kim, CD; Lee, HS; Lee, JH; Lee, TH; Shin, HK | 1 |
Chatterjee, S; Fisher, AB; Matsuzaki, I; Zhang, Q | 1 |
2 other study(ies) available for cromakalim and diphenyleneiodonium
Article | Year |
---|---|
Gene transfer of Cu/Zn SOD to cerebral vessels prevents FPI-induced CBF autoregulatory dysfunction.
Topics: Adenoviridae; Animals; Arteries; Brain; Brain Injuries; Calcitonin Gene-Related Peptide; Cerebrospinal Fluid; Cromakalim; Genetic Therapy; Genetic Vectors; Homeostasis; Humans; Hypotension; Male; NADPH Oxidases; Onium Compounds; Pia Mater; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides; Transfection; Vasodilation | 2002 |
Activation of endothelial NADPH oxidase during normoxic lung ischemia is KATP channel dependent.
Topics: Animals; Cromakalim; Endothelial Cells; Enzyme Inhibitors; Fluorescent Dyes; Ischemia; Lung; Membrane Glycoproteins; Membrane Potentials; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Onium Compounds; Pleura; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species; Vasodilator Agents | 2005 |